Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma
Dytfeld, Dominik, Jasielec, Jagoda, Griffith, Kent A, Lebovic, Daniel, Vesole, David H, Jagannath, Sundar, Al-Zoubi, Ammar, Anderson, Tara, Detweiler-Short, Kristen, Stockerl-Goldstein, Keith, Ahmed, Asra, Jobkar, Terri, Durecki, Diane E, McDonnell, Kathryn, Mietzel, Melissa, Couriel, Daniel, Kaminski, Mark, Vij, Ravi, Jakubowiak, Andrzej J
Published in Haematologica (Roma) (01.09.2014)
Published in Haematologica (Roma) (01.09.2014)
Get full text
Journal Article
A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma
Jakubowiak, Andrzej J., Dytfeld, Dominik, Griffith, Kent A., Lebovic, Daniel, Vesole, David H., Jagannath, Sundar, Al-Zoubi, Ammar, Anderson, Tara, Nordgren, Brian, Detweiler-Short, Kristen, Stockerl-Goldstein, Keith, Ahmed, Asra, Jobkar, Terri, Durecki, Diane E., McDonnell, Kathryn, Mietzel, Melissa, Couriel, Daniel, Kaminski, Mark, Vij, Ravi
Published in Blood (30.08.2012)
Published in Blood (30.08.2012)
Get full text
Journal Article
A Phase II Study of Consolidation Treatment with Iodione-131 Tositumomab (Bexxar™) in Multiple Myeloma (MM)
Lebovic, Daniel, Kaminski, Mark S., Anderson, Tara B., Detweiler-Short, Kristen, Griffith, Kent A., Jobkar, Terri L., Kandarpa, Malathi, Jakubowiak, Andrzej
Published in Blood (16.11.2012)
Published in Blood (16.11.2012)
Get full text
Journal Article
Treatment outcome with the combination of carfilzomib, lenalidomide, and low-dose dexamethasone (CRd) for newly diagnosed multiple myeloma (NDMM) after extended follow-up
Jakubowiak, Andrzej J., Dytfeld, Dominik, Griffith, Kent A., Jasielec, Jagoda, McDonnell, Kathryn, Lebovic, Daniel, Vesole, David H, Jagannath, Sundar, Chottiner, Elaine G., Anderson, Tara B., Detweiler-Short, Kristen, Stockerl-Goldstein, Keith, Ahmed, Asra Z., Jobkar, Terri L., Durecki, Diane E., Mietzel, Melissa A, Couriel, Daniel R., Vij, Ravi, Kaminski, Mark Stefan
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
Stringent complete response (sCR) in patients (pts) with newly diagnosed multiple myeloma (NDMM) treated with carfilzomib (CFZ), lenalidomide (LEN), and dexamethasone (DEX)
Jakubowiak, Andrzej J., Griffith, Kent A., Dytfeld, Dominik, Vesole, David H., Jagannath, Sundar, Anderson, Tara B., Nordgren, Brian K., Detweiler-Short, Kristen, Lebovic, Daniel, Stockerl-Goldstein, Keith, Jobkar, Terri L., Wear, Sandra Marija, Al-Zoubi, Ammar, Ahmed, Asra Z., Mietzel, Melissa A, Couriel, Daniel R., Kaminski, Mark Stefan, Hussein, Mohamad A., Yeganegi, Homa, Vij, Ravi
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
Final Results of a Frontline Phase 1/2 Study of Carfilzomib, Lenalidomide, and Low-Dose Dexamethasone (CRd) in Multiple Myeloma (MM)
Jakubowiak, Andrzej J, Dytfeld, Dominik, Jagannath, Sundar, Vesole, David H., Anderson, Tara B., Nordgren, Brian K., Detweiler-Short, Kristen, Lebovic, Daniel, Stockerl-Goldstein, Keith E., Griffith, Kent A., Jobkar, Terri L., Durecki, Diane E, Wear, Sandra M., Ott, Robert F, Al-Zoubi, Ammar, Mietzel, Melissa A, Hussein, M, Couriel, Daniel, Leveque, Joseph A, Vij, Ravi
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article